Lavipharm S.A.
LAVI
Rank in Stocks
#15056
Lavipharm S.A. is a company that specializes in the comprehensive lifecycle of... Lavipharm S.A. is a company that specializes in the comprehensive lifecycle of pharmaceutical, dermocosmetic, and general healthcare products, from initial research and development to manufacturing, importation, marketing, and distribution. Its operations span both the Greek domestic market and international territories. The company's diverse pharmaceutical offerings cater to numerous therapeutic areas, including cardiology, chronic pain management, oncology, central nervous system disorders, general medicine, gastrointestinal health, and urology. In addition to prescription medications, Lavipharm provides a range of over-the-counter (OTC) drugs such as antiseptics, analgesics, and anti-lice treatments, alongside various skincare solutions. This enterprise, headquartered in Paiania, Greece, was established in 1911.
Share Price
$1.67
Last synced: 2026-11-09
Market Cap
$285.19M
Change (1 day)
3.31%
Change (1 year)
75.57%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Lavipharm S.A. (LAVI)
Category
Healthcare
Operating Margin for Lavipharm S.A. (LAVI)
Operating Margin as of November 2026 TTM: 11.89%
According to Lavipharm S.A.'s latest financial reports, its current operating margin (TTM) is 11.89%. At the end of 2025 the company had an operating margin of 11.44%.
Operating Margin history for Lavipharm S.A. from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 11.89% | 3.93% |
| 2025 | 11.44% | 42.29% |
| 2024 | 8.04% | -2.07% |
| 2023 | 8.21% | 19.16% |
| 2022 | 6.89% | -789.00% |
| 2021 | -1.00% | -119.23% |
| 2020 | 5.20% | 99.23% |
| 2019 | 2.61% | -325.00% |
| 2018 | -1.16% | -130.85% |
| 2017 | 3.76% | -145.85% |
| 2016 | -8.20% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.37% |
DE
|
|
| 19.68% | -98.34% |
DE
|
|
| 13.26% | -98.88% |
JP
|
|
| 17.08% | -98.56% |
CH
|
|
| 14.92% | -98.75% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Lavipharm S.A.'s operating margin
What is Lavipharm S.A.'s operating margin?
Lavipharm S.A.'s operating margin is 11.89%, as of Nov 2026.
What was Lavipharm S.A.'s operating margin in 2025?
In 2025, Lavipharm S.A.'s operating margin was 11.44%, compared with 8.04% in 2024.
How has Lavipharm S.A.'s operating margin changed since 2020?
From 2020 to 2025, Lavipharm S.A.'s operating margin was highest in 2025 (11.44%) and lowest in 2021 (-1.00%).
How does Lavipharm S.A.'s operating margin compare with similar companies?
Lavipharm S.A.'s operating margin (11.89%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.